Related Experiment Video
Updated: May 25, 2026

Live/Dead Staining for Quantifying Viable but Not Culturable Cells in Manuka Honey-Treated Wound-Causing Bacteria
Published on: April 25, 2025
Methylglyoxal: (active agent of manuka honey) in vitro activity against bacterial biofilms
Shaun J Kilty1, Melanie Duval, Francis T Chan
1Department of Otolaryngology-Head and Neck Surgery, The Ottawa Hospital (TOH), Ottawa, Ontario, Canada. shaunkilty@hotmail.com
Background:
Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA) biofilms are associated with poor chronic rhinosinusitis (CRS) disease control following surgery. Manuka honey (MH) has been shown to be both an effective in vitro treatment agent for SA and PA biofilms and nontoxic to sinonasal respiratory mucosa. Methylglyoxal (MGO) has been reported to be the major antibacterial agent in MH. The effect of this agent against SA and PA biofilms has yet to be reported. Our objective was to determine the in vitro effect of MGO against biofilms of SA and PA, via in vitro testing of MGO against bacterial biofilms.
Methods:
An established biofilm model was used to determine the effective concentration (EC) of MGO against 10 isolates of methicillin-resistant SA (MRSA) and PA. The EC of MGO was also determined against planktonic (free-swimming) MRSA and PA.
Results:
For MRSA, the EC against planktonic organisms was a concentration of 0.08 mg/mL to 0.3 mg/mL whereas against the biofilm MRSA isolates, the EC ranged from 0.5 mg/mL to 3.6 mg/mL. For PA, the EC against planktonic organisms was a concentration of 0.15 mg/mL to 1.2 mg/mL for planktonic organisms whereas against the biofilm PA isolates, the EC ranged from 1.8 mg/mL to 7.3 mg/mL.
Conclusion:
MGO, a component of MH, is an effective antimicrobial agent against both planktonic and biofilm MRSA and PA organisms in vitro.
Insights
Methylglyoxal (MGO), a key component of Manuka honey (MH), effectively combats Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA) biofilms in laboratory settings. This study demonstrates MGO
Area of Science:
- Microbiology
- Infectious Diseases
- Otolaryngology
Background:
- Bacterial biofilms, particularly Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA), are implicated in poor outcomes for chronic rhinosinusitis (CRS).
- Manuka honey (MH) exhibits in vitro efficacy against SA and PA biofilms and is safe for sinonasal mucosa.
- Methylglyoxal (MGO) is identified as the primary antibacterial compound in MH, but its effect on biofilms was previously unreported.
Purpose of the Study:
- To investigate the in vitro antimicrobial activity of Methylglyoxal (MGO) against biofilms of Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA).
Main Methods:
- Utilized a standard in vitro biofilm model to assess the effective concentration (EC) of MGO.
- Tested MGO against 10 isolates each of methicillin-resistant SA (MRSA) and PA, including both biofilm and planktonic forms.
Main Results:
- For MRSA, MGO's EC against planktonic cells ranged from 0.08-0.3 mg/mL, while against biofilms it was 0.5-3.6 mg/mL.
- For PA, MGO's EC against planktonic cells ranged from 0.15-1.2 mg/mL, and against biofilms it was 1.8-7.3 mg/mL.
Conclusions:
- Methylglyoxal (MGO), derived from Manuka honey (MH), demonstrates significant in vitro antimicrobial effectiveness against both planktonic and biofilm forms of MRSA and PA.
- MGO presents a potential therapeutic agent for managing infections involving these challenging bacterial biofilms.
Related Concept Videos
Chemical Agents for Microbial Control
Inhibitors of Gram-positive Cell Wall Synthesis
Biofilms
Antimicrobial Effectiveness
Biological Methods for Microbial Control
Clinical Significance of Antibiotic Resistance
